Form4insider filings, from the source

SEC Form 3 · accession 0001661422-15-000001

ARENA PHARMACEUTICALS INC · ARNA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Maurice James Mezzino
Officer — SVP, Corporate Development
Period of report
Dec 16, 2015
Accepted (ET)
Dec 18, 2015 · 5:58 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001080709

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stockholding———8,763D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (right to buy)F1$1.48holding————Sep 15, 2021Common Stock61,220—D
Employee Stock Option (right to buy)F2$1.48holding————Oct 3, 2021Common Stock9,780—D
Employee Stock Option (right to buy)F3$1.81holding————Mar 19, 2022Common Stock75,000—D
Employee Stock Option (right to buy)F4$8.54holding————Mar 5, 2020Common Stock45,000—D
Employee Stock Option (right to buy)F5$6.80holding————Mar 3, 2021Common Stock60,000—D
Employee Stock Option (right to buy)F6$4.47holding————Mar 11, 2022Common Stock75,000—D

Explanation of responses